뭔가 하고 싶은 말이 있는거야?
컨텐츠 내용을 수정할 수 있습니다
A 32-year-old female presents with a 10-pound weight loss over 3 months despite increased appetite, heat intolerance, palpitations, and anxiety. Physical examination reveals tachycardia (HR 110), fine tremors of the outstretched hands, warm moist skin, and mild exophthalmos. These findings strongly suggest Graves' disease as the cause of hyperthyroidism.
T - Tachycardia
A - Anxiety
C - Cardiac palpitations
H - Heat intolerance
Y - Yearning for food (increased appetite)
D - Diarrhea
E - Exophthalmos (in Graves' disease)
R - Restlessness
M - Muscle weakness and tremors
A 45-year-old female presents with increasing fatigue, 15-pound weight gain over 6 months despite no change in diet, constipation, dry skin, and feeling cold when others are comfortable. Physical examination reveals bradycardia (HR 58), dry, coarse skin, puffy face, and delayed relaxation phase of deep tendon reflexes. Laboratory tests show elevated TSH (12 mIU/L) and low free T4 (0.6 ng/dL), consistent with primary hypothyroidism.
S - Slow heart rate (bradycardia)
L - Lethargy and fatigue
O - Oversensitivity to cold
W - Weight gain
D - Dry skin
O - Obstipation (constipation)
W - Weak, achy muscles
N - Nonspecific mental slowing
A 35-year-old female presents with an asymptomatic anterior neck mass discovered during a routine physical examination. Ultrasound reveals a 1.8 cm solid, hypoechoic nodule with irregular margins and microcalcifications in the right thyroid lobe. Fine needle aspiration biopsy shows cells with nuclear grooves and intranuclear inclusions. These findings are highly suggestive of papillary thyroid carcinoma, requiring surgical intervention.
| Feature | Hyperthyroidism | Hypothyroidism |
|---|---|---|
| Metabolic Rate | Increased | Decreased |
| Weight | Weight loss despite increased appetite | Weight gain despite decreased appetite |
| Heart Rate | Tachycardia (>100 bpm) | Bradycardia (<60 bpm) |
| Temperature Sensitivity | Heat intolerance, increased sweating | Cold intolerance, decreased sweating |
| Skin | Warm, moist, thin | Dry, cool, thick, puffy |
| Bowel Function | Diarrhea or frequent bowel movements | Constipation |
| Reflexes | Hyperreflexia | Delayed relaxation phase (hyporeflexia) |
| Mental Status | Anxiety, irritability, insomnia | Depression, lethargy, somnolence |
| Lab Values | ↓ TSH, ↑ T3/T4 | ↑ TSH, ↓ T3/T4 (primary) |
| Common Cause | Graves' disease | Hashimoto's thyroiditis |
| Emergency Complication | Thyroid storm | Myxedema coma |
| Medication | Use | Mechanism | Key Nursing Considerations |
|---|---|---|---|
| Levothyroxine (Synthroid, Levoxyl) | Hypothyroidism | Synthetic T4 hormone replacement | Take on empty stomach; multiple drug interactions; monitor for signs of over/under replacement |
| Liothyronine (Cytomel) | Hypothyroidism | Synthetic T3 hormone replacement | Shorter half-life than T4; more rapid onset; higher risk of cardiac effects |
| Methimazole (Tapazole) | Hyperthyroidism | Blocks thyroid hormone synthesis | Monitor for agranulocytosis (sore throat, fever); preferred in pregnancy after 1st trimester |
| Propylthiouracil (PTU) | Hyperthyroidism | Blocks thyroid hormone synthesis and peripheral conversion of T4 to T3 | Risk of hepatotoxicity; preferred in 1st trimester pregnancy and thyroid storm |
| Propranolol (Inderal) | Hyperthyroidism symptom control | Beta-blocker; blocks adrenergic effects | Reduces heart rate, tremor, and anxiety; does not affect thyroid hormone levels |
| Radioactive Iodine (I-131) | Hyperthyroidism treatment | Destroys thyroid tissue | Contraindicated in pregnancy; radiation precautions; often leads to hypothyroidism |
| Type | Frequency | Characteristics | Prognosis |
|---|---|---|---|
| Papillary | 80-85% | Slow-growing; lymphatic spread; nuclear inclusions and grooves on pathology | Excellent (>95% 10-year survival) |
| Follicular | 10-15% | Hematogenous spread; encapsulated; more common in iodine-deficient areas | Good (85-90% 10-year survival) |
| Medullary | 5-10% | Arises from C-cells; produces calcitonin; may be part of MEN2 syndrome | Intermediate (75% 10-year survival) |
| Anaplastic | 1-2% | Aggressive; rapid growth; affects elderly; presents with compressive symptoms | Poor (3-6 month median survival) |
Thyroid Storm: Presents with extreme tachycardia (>140 bpm), hyperthermia (>104°F/40°C), CNS dysfunction (agitation to coma), and GI symptoms. Mortality rate 20-30% even with treatment. Requires immediate beta-blockers, antithyroid drugs, cooling measures, and supportive care.
Myxedema Coma: Characterized by hypothermia, hypotension, hypoventilation, hyponatremia, and altered mental status. Mortality 30-60%. Treatment includes IV levothyroxine, hydrocortisone, warming, and supportive measures.
Remember the relationship between TSH and T4:
- Primary hypothyroidism: ↑ TSH, ↓ T4 (thyroid problem)
- Primary hyperthyroidism: ↓ TSH, ↑ T4 (thyroid problem)
- Secondary hypothyroidism: ↓ TSH, ↓ T4 (pituitary problem)
- Subclinical hypothyroidism: ↑ TSH, normal T4
- Subclinical hyperthyroidism: ↓ TSH, normal T4
For questions about thyroid disorders:
1. Identify if the scenario describes hyper- or hypothyroidism
2. Consider the severity (emergency vs. chronic management)
3. Look for keywords indicating complications (e.g., "storm," "coma")
4. For medication questions, consider timing, interactions, and monitoring
5. Remember that psychosocial support is important but rarely the highest priority in acute situations
Confusing TSH Interpretation: Remember that TSH has an inverse relationship with thyroid function. A high TSH indicates the pituitary is trying to stimulate an underactive thyroid (hypothyroidism), while a low TSH indicates the pituitary is suppressed due to excessive thyroid hormone (hyperthyroidism).
Overlooking Subtle Presentations: Elderly patients often present with atypical or subtle symptoms of thyroid dysfunction. "Apathetic hyperthyroidism" in the elderly may present primarily with weight loss and cardiac symptoms rather than the classic hypermetabolic state.
Medication Timing: Students often forget that levothyroxine should be taken on an empty stomach, 30-60 minutes before breakfast or 3-4 hours after the last meal, to ensure proper absorption.
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.